These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Evaluation of chromosome 1q gain in intracranial ependymomas. Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups. Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma. Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534 [TBL] [Abstract][Full Text] [Related]
11. Supratentorial ependymoma in childhood: more than just RELA or YAP. Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105 [TBL] [Abstract][Full Text] [Related]
12. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? Sainati L; Montaldi A; Putti MC; Giangaspero F; Rigobello L; Stella M; Zanesco L; Basso G Cancer Genet Cytogenet; 1992 Apr; 59(2):213-6. PubMed ID: 1581886 [TBL] [Abstract][Full Text] [Related]
14. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077 [TBL] [Abstract][Full Text] [Related]
15. Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome. Jünger ST; Andreiuolo F; Mynarek M; Dörner E; Zur Mühlen A; Rutkowski S; von Bueren AO; Pietsch T Childs Nerv Syst; 2020 Nov; 36(11):2693-2700. PubMed ID: 32474813 [TBL] [Abstract][Full Text] [Related]
16. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis. Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744 [TBL] [Abstract][Full Text] [Related]
17. Utility of copy number variants in the classification of intracranial ependymoma. Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935 [TBL] [Abstract][Full Text] [Related]